Video

Machine learning software boosts colonoscopists’ adenoma detection rates


 

REPORTING FROM DDW 2018

Researchers have developed software that can identify or rule out adenomatous polyps that’s fast enough to potentially aid colonoscopists in real time to boost their adenoma detection rate.

When tested on 36,076 archived colonoscopy images, the polyp recognition program developed through machine learning had a sensitivity for polyp detection of 98%, a specificity of 93%, a positive predictive value of 0.758 and a negative predictive value of 0.995, Priyam V. Tripathi, MD, said at the annual Digestive Disease Week.® The program also showed an area under the receiver operator characteristic curve of 0.99, indicating nearly perfect ability to discriminate between images of polyps and normal colonic tissue, said Dr. Tripathi, a gastroenterologist at the University of California, Irvine.

She and her associates initially developed the polyp-recognition program with machine learning engineering that involved 4,088 images of polyps and 4,553 images of normal tissue drawn from the extensive colonoscopy video archive maintained at UC Irvine. Refinement of the program continues as it undergoes further use. The program can review 98 images a second, making it more than fast enough to aid during real-time colonoscopy examinations, Dr. Tripathi explained in a video interview. As an operator withdraws the colonoscope and views the images, the program is designed to monitor the pictures along with the operator and trigger alerts that flag high-probability lesions by framing them in a colored box on the screen. The operator can then examine these sites with more attention and decide whether they warrant biopsy or polypectomy.

A second validation study used the program to review 20 archived colonoscopy videos along with an expert panel. During the original examinations, the operators of these 20 procedures identified 28 polyps. The expert review confirmed these 28 and identified eight additional polyps. The researchers then assessed the same videos with the recognition program and confirmed the original 28 plus the added eight and also found nine additional polyps that had been missed twice by clinicians. Dr. Tripathi and her associates recently published results from this validation study (Gastroenterology. 2018 Jun 18. doi: 10.1053/j.gastro.2018.06.037).

The next step is a prospective, multicenter study to compare the adenoma detection rate of operators aided by the recognition program with their detection rate without the program, she said.

mzoler@mdedge.com

SOURCE: Tripathi PV et al. DDW 2018. Presentation 133.

Recommended Reading

PREOPANC-1: Early findings suggest benefit with preop chemo in pancreatic cancer
MDedge Hematology and Oncology
Rural cancer patients report faster care than urban counterparts
MDedge Hematology and Oncology
Pancreatic cancer has a pancreatopathy distinct from type 2 diabetes
MDedge Hematology and Oncology
Recurrence of a small gastric gastrointestinal stromal tumor with high mitotic index
MDedge Hematology and Oncology
Ramucirumab improves HCC survival after sorafenib failure
MDedge Hematology and Oncology
Pembrolizumab does not surpass paclitaxel for gastric cancer
MDedge Hematology and Oncology
Trifluridine/tipiracil improves survival of metastatic gastric cancer
MDedge Hematology and Oncology
Hints of nivolumab efficacy seen in biliary tract cancers
MDedge Hematology and Oncology
Screen sooner and more often for those with family history of CRC
MDedge Hematology and Oncology
Neuropilin-1 surpasses AFP as HCC diagnostic marker
MDedge Hematology and Oncology